FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Locally Advanced Unresectable or Metastatic HER2-Negative Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Approval based on results from the Phase 3 KEYNOTE-859 trial, which demonstrated significant improvement in overall survival in these patients versus chemotherapy... Read more.
Virtus Artificial Intelligence & Technology Opportunities Fund Announces Distributions and Discloses Sources of Distribution – Section 19(a) Notice
HARTFORD, Conn.–(BUSINESS WIRE)–Virtus Artificial Intelligence & Technology Opportunities Fund (NYSE: AIO) today announced the following monthly... Read more.
Virtus Diversified Income & Convertible Fund Announces Distributions and Discloses Sources of Distribution – Section 19(a) Notice
HARTFORD, Conn.–(BUSINESS WIRE)–Virtus Diversified Income & Convertible Fund (NYSE: ACV) today announced the following monthly distributions: Amount... Read more.
Arco to Provide Supplemental Materials for Extraordinary General Meeting of Shareholders
SÃO PAULO–(BUSINESS WIRE)–Arco Platform Limited (Nasdaq: ARCE) (“Arco” or the “Company”), a leading operating system for K-12 schools, previously... Read more.
NRG Energy Celebrates Business Customers During Fourth Annual Excellence in Energy Awards
HOUSTON–(BUSINESS WIRE)–NRG Energy, Inc. (NYSE: NRG) honored some of its top energy customers today for their leadership in community, sustainability,... Read more.
EverGen Infrastructure Announces Dates for 2023 Third Quarter Financial Results and Conference Call
VANCOUVER, British Columbia–(BUSINESS WIRE)–EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQX: EVGIF), today announced... Read more.
UGI Reports Fiscal 2023 Results
Issues Fiscal 2024 Guidance VALLEY FORGE, Pa.–(BUSINESS WIRE)–#FY2023–UGI Corporation (NYSE: UGI) reported financial results for the fiscal year... Read more.
Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q
MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and... Read more.
Cyxtera Receives Court Approval for Sale to Brookfield and Plan of Reorganization
Transaction positions company to increase data center facility ownership, pursue expansion opportunities that support robust customer demand, and drive next phase... Read more.
QuidelOrtho to Participate in the Evercore ISI Conference
SAN DIEGO–(BUSINESS WIRE)–QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies... Read more.